A Study in Greece Observing How Patients With Stomach and Esophageal Cancer Are Diagnosed and Treated in Everyday Medical Practice
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
This is a retrospective-prospective observational, multicenter, single-country study aiming to describe the epidemiological characteristics and management strategies in patients with stage II-IVB gastric/GEJ adenocarcinoma in routine clinical practice in Greece.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Wiek co najmniej 18 lat w momencie rozpoznania raka
- •Potwierdzony histologicznie rak żołądka, etap II-IVB
- •Diagnoza postawiona między czerwcem 2025 a trzecim kwartałem 2027
- •Podpisana pisemna zgoda pacjenta (lub jego opiekuna prawnego)
✗ Disqualifies
- •Uczestnictwo w innym badaniu klinicznym z nowymi lekami lub metodami leczenia
- •Inny nowotwór złośliwy w ostatnich 5 latach wymagający chemioterapii
- •Pracownik badania lub jego krewny zaangażowany w projekt
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Maximum age
- 130 Years
- Last updated (source)
- October 8, 2026
- Sex
- No restrictions
Locations (8)
Research Site
Alexandroupoli, Greece
Research Site
Athens, Greece
Research Site
Athens, Greece
Research Site
Athens, Greece
Research Site
Crete, Greece
Research Site
Ioannina, Greece
Research Site
Pátrai, Greece
Research Site
Thessaloniki, Greece
Trial contact
AstraZeneca Clinical Study Information Center
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 10/9/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.